295 related articles for article (PubMed ID: 9815568)
1. Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients.
Kos J; Stabuc B; Schweiger A; Krasovec M; Cimerman N; Kopitar-Jerala N; Vrhovec I
Clin Cancer Res; 1997 Oct; 3(10):1815-22. PubMed ID: 9815568
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases, but not cathepsins B, H, and L or their inhibitors in peripheral blood of patients with rheumatoid arthritis are potentially useful markers of disease activity.
Keyszer G; Lambiri I; Keysser M; Keysser C; Nagel R; Burmester GR; Jung K
Z Rheumatol; 1998 Dec; 57(6):392-8. PubMed ID: 10025098
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of cysteine proteinases cathepsins B and L and their endogenous inhibitors stefins A and B in patients with squamous cell carcinoma of the head and neck.
Strojan P; Budihna M; Smid L; Svetic B; Vrhovec I; Kos J; Skrk J
Clin Cancer Res; 2000 Mar; 6(3):1052-62. PubMed ID: 10741734
[TBL] [Abstract][Full Text] [Related]
4. Circadian characteristics of cathepsins B, H, L, and stefins A and B, potential markers for disease, in normal sera.
Cimerman N; Brguljan PM; Krasovec M; Suskovic S; Kos J
Clin Chim Acta; 1999 Apr; 282(1-2):211-8. PubMed ID: 10340450
[No Abstract] [Full Text] [Related]
5. Lysosomal cathepsins B and L and Stefin A blood levels in patients with hepatocellular carcinoma and/or liver cirrhosis: potential clinical implications.
Leto G; Tumminello FM; Pizzolanti G; Montalto G; Soresi M; Gebbia N
Oncology; 1997; 54(1):79-83. PubMed ID: 8978598
[TBL] [Abstract][Full Text] [Related]
6. Serum concentration and circadian profiles of cathepsins B, H and L, and their inhibitors, stefins A and B, in asthma.
Cimerman N; Mesko Brguljan P; Krasovec M; Suskovic S; Kos J
Clin Chim Acta; 2001 Aug; 310(2):113-22. PubMed ID: 11498076
[TBL] [Abstract][Full Text] [Related]
7. Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relation to prognosis.
Kos J; Krasovec M; Cimerman N; Nielsen HJ; Christensen IJ; Brünner N
Clin Cancer Res; 2000 Feb; 6(2):505-11. PubMed ID: 10690531
[TBL] [Abstract][Full Text] [Related]
8. Cathepsins B and L are markers for clinically invasive types of meningiomas.
Strojnik T; Zidanik B; Kos J; Lah TT
Neurosurgery; 2001 Mar; 48(3):598-605. PubMed ID: 11270551
[TBL] [Abstract][Full Text] [Related]
9. Comparison of potential biological markers cathepsin B, cathepsin L, stefin A and stefin B with urokinase and plasminogen activator inhibitor-1 and clinicopathological data of breast carcinoma patients.
Levicar N; Kos J; Blejec A; Golouh R; Vrhovec I; Frkovic-Grazio S; Lah TT
Cancer Detect Prev; 2002; 26(1):42-9. PubMed ID: 12088202
[TBL] [Abstract][Full Text] [Related]
10. Cathepsins B and L and their inhibitors stefin B and cystatin C as markers for malignant progression of benign meningiomas.
Trinkaus M; Vranic A; Dolenc VV; Lah TT
Int J Biol Markers; 2005; 20(1):50-9. PubMed ID: 15832773
[TBL] [Abstract][Full Text] [Related]
11. Cathepsin B, cathepsin H, cathepsin X and cystatin C in sera of patients with early-stage and inflammatory breast cancer.
Decock J; Obermajer N; Vozelj S; Hendrickx W; Paridaens R; Kos J
Int J Biol Markers; 2008; 23(3):161-8. PubMed ID: 18949742
[TBL] [Abstract][Full Text] [Related]
12. Cystatin C and cysteine proteinases during the development and therapy of Lewis lung adenocarcinoma in mice.
Usova TA; Poteryaeva ON; Zhanayeva SY; Yarygina ES; Korolenko TA
Bull Exp Biol Med; 2003 Jan; 135(1):81-4. PubMed ID: 12717521
[TBL] [Abstract][Full Text] [Related]
13. Human cysteine proteinases and their protein inhibitors stefins, cystatins and kininogens.
Turk V; Brzin J; Kotnik M; Lenarcic B; Popović T; Ritonja A; Trstenjak M; Begić-Odobasić L; Machleidt W
Biomed Biochim Acta; 1986; 45(11-12):1375-84. PubMed ID: 3495261
[TBL] [Abstract][Full Text] [Related]
14. A possible role for cysteine proteinase and its inhibitors in motility of malignant melanoma and other tumour cells.
Boike G; Lah T; Sloane BF; Rozhin J; Honn K; Guirguis R; Stracke ML; Liotta LA; Schiffmann E
Melanoma Res; 1992; 1(5-6):333-40. PubMed ID: 1422189
[TBL] [Abstract][Full Text] [Related]
15. Cystatins and cathepsins in breast carcinoma.
Lah TT; Kokalj-Kunovar M; Drobnic-Kosorok M; Babnik J; Golouh R; Vrhovec I; Turk V
Biol Chem Hoppe Seyler; 1992 Jul; 373(7):595-604. PubMed ID: 1515089
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of the cysteine proteases cathepsins B and cathepsin L in human breast cancer.
Thomssen C; Schmitt M; Goretzki L; Oppelt P; Pache L; Dettmar P; Jänicke F; Graeff H
Clin Cancer Res; 1995 Jul; 1(7):741-6. PubMed ID: 9816040
[TBL] [Abstract][Full Text] [Related]
17. Cathepsin expression in oral squamous cell carcinoma: relationship with clinicopathologic factors.
Kawasaki G; Kato Y; Mizuno A
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Apr; 93(4):446-54. PubMed ID: 12029284
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of cathepsins B, H, L, D and their endogenous inhibitors stefins A and B in head and neck carcinoma.
Budihna M; Strojan P; Smid L; Skrk J; Vrhovec I; Zupevc A; Rudolf Z; Zargi M; Krasovec M; Svetic B; Kopitar-Jerala N; Kos J
Biol Chem Hoppe Seyler; 1996 Jun; 377(6):385-90. PubMed ID: 8839984
[TBL] [Abstract][Full Text] [Related]
19. Serum cathepsin H as a potential prognostic marker in patients with colorectal cancer.
Schweiger A; Christensen IJ; Nielsen HJ; Sørensen S; Brünner N; Kos J
Int J Biol Markers; 2004; 19(4):289-94. PubMed ID: 15646835
[TBL] [Abstract][Full Text] [Related]
20. Structural basis for different inhibitory specificities of human cystatins C and D.
Hall A; Ekiel I; Mason RW; Kasprzykowski F; Grubb A; Abrahamson M
Biochemistry; 1998 Mar; 37(12):4071-9. PubMed ID: 9521728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
